Blog
Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.
Page 39
Rat Achilles study: BPC-157 and TB-500
A 32-rat Achilles repair study found TB-500 improved load to failure and tendon histology at four weeks. BPC-157 did not reach significance.
CJC-1295 Q3 2026: what changed
Q3 2026 update on CJC-1295: new sports-medicine reviews, Topol cancer-risk commentary, WADA detection advances, and the regulatory picture as of August 2026.
The first week on ipamorelin and CJC-1295
Two good nights on an ipamorelin and CJC-1295 blend is not a result yet. Here is what the published timelines actually look like.
Ipamorelin + CJC-1295: early effects
Community reports of better sleep within days of starting ipamorelin and CJC-1295 align with GH-axis pharmacology. Here is what the published literature says.
Peptide blood tests before and after
What a before and after blood panel can show around retatrutide, hCG or Semax, what it cannot, and why interpretation belongs with a clinician.
Why you cannot tell which peptide did it
Running BPC-157, TB-500 and tirzepatide together makes every result uninterpretable. Here is why pharmacology treats one variable at a time.
Peptide stacking: the attribution problem
Running six research peptides at once creates an attribution problem you cannot solve. Here is what the evidence says about polypharmacy risk and safety gaps.
PT-141 microdosing: what the evidence shows
PT-141 is FDA-approved at 1.75 mg, where nausea runs at 40% in trials. Here is what the evidence says about lower doses.
Retatrutide + GHK-Cu + ipamorelin stack
What the research says about each compound and the key data gaps before combining retatrutide, GHK-Cu, and ipamorelin with CJC-1295 No DAC.
Semax + Selank subq: together or apart?
A common question in peptide communities: should Semax and Selank be injected at the same time or spaced out? Here is what the pharmacology says.
Semax and Selank together: the evidence
Semax and Selank are Russian nootropic peptides with small, mostly Russian-language trial records. No published study has given both to the same person.
Stacking peptides on top of retatrutide
Readers ask about adding GHK-Cu, ipamorelin and CJC-1295 to retatrutide. No published human trial has tested any of those combinations.